US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Elutia

1.88

-0.0200-1.05%

Post-market: 1.880.00000.00%16:00 EDT

Volume:59.27K

Turnover:112.20K

Market Cap:76.59M

PE:-1.01

High:2.05

Open:1.98

Low:1.79

Close:1.90

Loading ...

Overview Company News Filings

Elutia Inc. Ends Distribution Agreement with LeMaitre

Elutia Inc expected to post a loss of 20 cents a share - Earnings Preview

Elutia reclaims sales, distribution for cardiovascular portfolio

Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio

Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

Elutia Confirms No Material Impact From Global Tariffs

THOMSON REUTERS

BRIEF-Elutia Inc May Offer & Sell Up To $50.0 Million Of Shares Of Class A Common Stock - SEC Filing

Elutia Inc May Offer & Sell up to $50.0 Mln of Shares of Class a Common Stock - SEC Filing

THOMSON REUTERS

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

BRIEF-Elutia Announces GPO Agreement With Advantus Health Partners To Expand Access To EluPro

Elutia announces GPO agreement with Advantus Health Partners

Elutia Announces Gpo Agreement With Advantus Health Partners to Expand Access to Elupro™

THOMSON REUTERS

Press Release: Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro(TM)

BRIEF-Elutia Files For Mixed Shelf Of Up To $100 Million – SEC Filing

Elutia Inc Files for Mixed Shelf of up to $100 Mln – SEC Filing

THOMSON REUTERS

Elutia : Sales Agreement Prospectus Covering Issuance of up to $50 Mln of Class a Common Stock That May Be Issued Under Sales Agreement

THOMSON REUTERS

Elutia Price Target Maintained With a $8.00/Share by Cantor Fitzgerald

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Aziyo Biologics (ELUT) and IGM Biosciences (IGMS)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ELUT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELUT\",,,,,undefined,":{"symbol":"ELUT","market":"US","secType":"STK","nameCN":"Elutia","latestPrice":1.88,"timestamp":1746561600000,"preClose":1.9,"halted":0,"volume":59268,"hourTrading":{"tag":"盘后","latestPrice":1.88,"preClose":1.88,"latestTime":"16:00 EDT","volume":104,"amount":195.51999999999998,"timestamp":1746561601886},"delay":0,"floatShares":19876749,"shares":40736888,"eps":-1.855759,"marketStatus":"Not Yet Opened","change":-0.02,"latestTime":"05-06 16:00:00 EDT","open":1.98,"high":2.0499,"low":1.79,"amount":112197.4706,"amplitude":0.136789,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.855759,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746604800000},"marketStatusCode":0,"adr":0,"listingDate":1602129600000,"exchange":"NASDAQ","adjPreClose":1.9,"postHourTrading":{"tag":"盘后","latestPrice":1.88,"preClose":1.88,"latestTime":"16:00 EDT","volume":104,"amount":195.51999999999998,"timestamp":1746561601886},"volumeRatio":0.866656},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELUT\",,,,,undefined,":{"symbol":"ELUT","floatShares":19876749,"roa":"-38.15%","roe":"--","lyrEps":-1.855759,"volumeRatio":0.866656,"shares":40736888,"dividePrice":0,"high":2.0499,"amplitude":0.136789,"preClose":1.9,"low":1.79,"week52Low":1.79,"pbRate":"-1.66","psRate":"3.14","week52High":5.24,"institutionHeld":0,"latestPrice":1.88,"eps":-1.855759,"divideRate":0,"volume":59268,"delay":0,"ttmEps":-1.855759,"open":1.98,"prevYearClose":3.74,"prevWeekClose":2.04,"prevMonthClose":2.31,"prevQuarterClose":2.53,"fiveDayClose":2.24,"twentyDayClose":2.58,"sixtyDayClose":2.68,"earningDate":1746633600000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELUT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533693858","title":"Elutia Inc. Ends Distribution Agreement with LeMaitre","url":"https://stock-news.laohu8.com/highlight/detail?id=2533693858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533693858?lang=en_us&edition=fundamental","pubTime":"2025-05-07 05:15","pubTimestamp":1746566134,"startTime":"0","endTime":"0","summary":"An update from Aziyo Biologics ( ($ELUT) ) is now available. On April 30, 2025, Elutia Inc. ended its distribution agreement with LeMaitre Vascular...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elutia-inc-ends-distribution-agreement-with-lemaitre?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elutia-inc-ends-distribution-agreement-with-lemaitre?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2533766789","title":"Elutia Inc  expected to post a loss of 20 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533766789","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533766789?lang=en_us&edition=fundamental","pubTime":"2025-05-07 04:34","pubTimestamp":1746563658,"startTime":"0","endTime":"0","summary":"Elutia Inc  expected to post a loss of20cents a share - Earnings Preview Elutia Inc ELUT.OQ ELUT.O is expected to show a fall in quarterly revenue when it reports  results on May 8 for the period endi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nL8N3RE321:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"gpt_icon":0},{"id":"2532839100","title":"Elutia reclaims sales, distribution for cardiovascular portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2532839100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532839100?lang=en_us&edition=fundamental","pubTime":"2025-05-02 05:25","pubTimestamp":1746134729,"startTime":"0","endTime":"0","summary":"Elutia (ELUT) announced it is reclaiming U.S. sales and distribution responsibilities for its cardiovascular portfolio-including ProxiCor, VasCure ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elutia-reclaims-sales-distribution-for-cardiovascular-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elutia-reclaims-sales-distribution-for-cardiovascular-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELUT"],"gpt_icon":0},{"id":"2532839633","title":"Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2532839633","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532839633?lang=en_us&edition=fundamental","pubTime":"2025-05-02 04:05","pubTimestamp":1746129900,"startTime":"0","endTime":"0","summary":"Move expected to drive both top-line growth and gross margin improvement. SILVER SPRING, Md., May 01, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix products, today announced it is reclaiming U.S. sales and distribution responsibilities for its cardiovascular portfolio—including ProxiCor, VasCure, and Tyke—following the conclusion of its distribution agreement with LeMaitre Vascular, Inc. The move allows Elutia to directly capture top-line revenue and should improve the gross margin and profitability of this product segment.Elutia has appointed Dwayne Montgomery as Head of Cardiovascular to lead this newly established business unit. A seasoned commercial executive, Mr. Montgomery brings proven senior leadership experience from Osiris Therapeutics, Smith & Nephew, Guidant, and C.R. Bard.Under Mr. Montgomery’s leadership, Elutia has recruited and mobilized a high-performing team of 26 independent  sales representatives specifically for the cardiovascular line. Operating inde","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elutia-transitions-direct-distribution-cardiovascular-200500605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ELUT","BK4082","BK4139","CSII"],"gpt_icon":0},{"id":"2532074043","title":"Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532074043","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532074043?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:00","pubTimestamp":1746100800,"startTime":"0","endTime":"0","summary":"SILVER SPRING, Md., May 01, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2025 financial results after market close on Thursday, May 8, 2025. Members of the Company’s management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day.The conference call can be accessed using the following information:. Webcast: Click hereU.S. Investors: 877-407-8029International Investors: 201-689-8029Conference ID: 13753035. About ElutiaElutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.This press release was published by a CLEAR Verified individual.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elutia-report-first-quarter-2025-120000949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2529755251","title":"Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2529755251","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529755251?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:05","pubTimestamp":1745352300,"startTime":"0","endTime":"0","summary":"SILVER SPRING, Md., April 22, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participate in Chardan’s Trending Issues in Drug Development Conference Series on Tuesday, April 29, 2025.About ElutiaElutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.This press release was published by a CLEAR Verified individual.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elutia-participate-chardan-trending-issues-200500246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2529806578","title":"Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice","url":"https://stock-news.laohu8.com/highlight/detail?id=2529806578","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529806578?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:00","pubTimestamp":1745236800,"startTime":"0","endTime":"0","summary":"— Integration of clinical and patient-reported outcomes expected to further differentiate EluPro’s utility in cardiac implantable electronic device  procedures —。“Every innovation we pursue is driven by a commitment to improving patient care,” saidKimberly Mulligan, PhD, Vice President and General Manager of Cardiovascularat Elutia. “With EluPro, we combined trusted antibiotics with a soft, regenerative biomatrix to protect the implant, facilitate implantation, and support healing. This study will allow us to collect data on these differentiating characteristics in real-world practice.”The multi-center clinical study is a prospective, post-market study designed to evaluate the use of EluPro in standard clinical practice and its performance across a diverse population of patients undergoing CIED implantation. Data on clinical and patient-reported outcomes will be collected, which will include assessments of key complications of interest following CIED implantation - such as infection, h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elutia-initiates-elupro-registry-study-120000062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2527393154","title":"Elutia Confirms No Material Impact From Global Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527393154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527393154?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:00","pubTimestamp":1744632004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QR02N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2526646510","title":"BRIEF-Elutia Inc May Offer & Sell Up To $50.0 Million Of Shares Of Class A Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2526646510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526646510?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:25","pubTimestamp":1744403110,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Inc May Offer & Sell Up To $50.0 Million Of Shares Of Class A Common Stock - SEC FilingApril 11  - Elutia Inc ELUT.O:ELUTIA INC MAY OFFER & SELL UP TO $50.0 MILLION OF SHARES OF CLASS A COMMON STOCK - SEC FILINGSource text: [ID:n0001104659-25-034215]Further company coverage: ELUT.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nFWN3QP11C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2526646857","title":"Elutia Inc May Offer & Sell up to $50.0 Mln of Shares of Class a Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2526646857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526646857?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:22","pubTimestamp":1744402974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nFWN3QP11C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2524445043","title":"Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes","url":"https://stock-news.laohu8.com/highlight/detail?id=2524445043","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524445043?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:05","pubTimestamp":1743624300,"startTime":"0","endTime":"0","summary":"Introduction of EluPro at HeartRhythm2025 in San Diego, April 25-27,2025. SILVER SPRING, Md., April 02, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix products, is proud to announce the debut of its EluPro Antibiotic-Eluting BioEnvelope designed for cardiac implantable electronic devices  and neurostimulators at the Heart Rhythm Society’s annual meeting . Attendees will have the opportunity to experience firsthand the soft, conforming feel of EluPro and discover how its natural biomatrix supports healing while delivering trusted antibiotics to reduce bacterial colonization.Engineered for both performance and handling, EluPro features a proprietary biomatrix that drapes naturally around CIEDs, avoiding the rough, stiff feel often associated with synthetic alternatives. Combined with a trusted dual-antibiotic combination, EluPro offers physicians a solution designed for both efficacy and ease of use without compromise.“We are thrilled to introduce EluPro at HRS 2025 and give","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elutia-debut-elupro-hrs-2025-200500045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2522532500","title":"BRIEF-Elutia Announces GPO Agreement With Advantus Health Partners To Expand Access To EluPro","url":"https://stock-news.laohu8.com/highlight/detail?id=2522532500","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522532500?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:54","pubTimestamp":1743108871,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Announces GPO Agreement With Advantus Health Partners To Expand Access To EluProMarch 27 (Reuters) - Elutia Inc ELUT.O:ELUTIA ANNOUNCES GPO AGREEMENT WITH ADVANTUS HEALTH PARTNERS TO EXPA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA1DRWW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2522938531","title":"Elutia announces GPO agreement with Advantus Health Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2522938531","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522938531?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:20","pubTimestamp":1743106834,"startTime":"0","endTime":"0","summary":"Elutia (ELUT) announced that it has entered into an agreement with Advantus Health Partners to provide access of Elutia’s EluPro Antibiotic Eluting...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elutia-announces-gpo-agreement-with-advantus-health-partners?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elutia-announces-gpo-agreement-with-advantus-health-partners?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2522539622","title":"Elutia Announces Gpo Agreement With Advantus Health Partners to Expand Access to Elupro™","url":"https://stock-news.laohu8.com/highlight/detail?id=2522539622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522539622?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105923,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA1DRWW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2522539478","title":"Press Release: Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro(TM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522539478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522539478?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"SILVER SPRING, Md., March 27, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix products, announced that it has entered into an agreement with Advantus Health Partners , to provide access of Elutia's EluPro Antibiotic Eluting BioEnvelope to Advantus' core group purchasing organizations  solutions portfolio.\"Teaming up with Advantus is another major step forward in meeting the strong customer demand for EluPro,\" said Dr. Kimberly Mulligan, GM and VP of Elutia's Cardiovascular Division. \"Our pilot launch of EluPro has exceeded our expectations as physicians recognize the unique value that this antibiotic envelope brings in preventing infection for patients that use a cardiac implantable electronic device. Broadening our GPO coverage with Advantus allows us to benefit from their sustainable contracting solutions, making EluPro more widely available to physicians nationwide.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","ELUT","R","03160","BK4588","BK4139","BK4099","BK4232","TM","BK4604","BK4555","BK4585"],"gpt_icon":0},{"id":"2520642841","title":"BRIEF-Elutia Files For Mixed Shelf Of Up To $100 Million – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2520642841","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520642841?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:23","pubTimestamp":1742293425,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Files For Mixed Shelf Of Up To $100 Million – SEC FilingMarch 18  - Elutia Inc ELUT.O:ELUTIA INC FILES FOR MIXED SHELF OF UP TO $100 MILLION – SEC FILINGELUTIA : SALES AGREEMENT PROSPECTUS COVERING ISSUANCE OF UP TO $50 MILLION OF CLASS A COMMON STOCK THAT MAY BE ISSUED UNDER SALES AGREEMENTSource text: [ID:n0001104659-25-024551]Further company coverage: ELUT.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q01AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2520651644","title":"Elutia Inc Files for Mixed Shelf of up to $100 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2520651644","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520651644?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:16","pubTimestamp":1742293003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q01AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2520644644","title":"Elutia : Sales Agreement Prospectus Covering Issuance of up to $50 Mln of Class a Common Stock That May Be Issued Under Sales Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2520644644","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520644644?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:16","pubTimestamp":1742293003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q01AH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2517458273","title":"Elutia Price Target Maintained With a $8.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458273","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517458273?lang=en_us&edition=fundamental","pubTime":"2025-03-08 00:26","pubTimestamp":1741364760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELUT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 07, 2025 11:26 ET (16:26 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"gpt_icon":0},{"id":"2517554435","title":"Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Aziyo Biologics (ELUT) and IGM Biosciences (IGMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517554435","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517554435?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:51","pubTimestamp":1741355465,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Phathom Pharmaceuticals (PHAT – Research Report), Aziyo Biologics...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-aziyo-biologics-elut-and-igm-biosciences-igms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-aziyo-biologics-elut-and-igm-biosciences-igms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4007","BK4137","IGMS","PHAT","IGM","ELUT","HCSG","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELUT\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"ELUT","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1746734400000,"name":null,"time":"Post Market","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-03-06","symbol":"ELUT","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-11-14","symbol":"ELUT","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2024-08-07","symbol":"ELUT","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2024-05-09","symbol":"ELUT","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELUT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1695960000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELUT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELUT","date":"2025-05-05","current":-1.540404,"percent":0.804124,"low":-3.086243,"twenty":-2.381173,"median":-1.978826,"eighty":-1.56918,"high":-0.540943,"avg":-1.910506,"sd":0.533106,"marketCap":83103251},"quantilePoints":[{"date":"2023-09-15","current":-0.550518,"twenty":-0.608921,"median":-0.57924,"eighty":-0.548603,"marketCap":18687324},{"date":"2023-09-22","current":-0.732428,"twenty":-0.740087,"median":-0.598389,"eighty":-0.548603,"marketCap":24862265},{"date":"2023-09-29","current":-0.925604,"twenty":-0.854822,"median":-0.732428,"eighty":-0.573496,"marketCap":31419614},{"date":"2023-10-06","current":-0.877962,"twenty":-0.929687,"median":-0.810097,"eighty":-0.59073,"marketCap":29802428},{"date":"2023-10-13","current":-0.925604,"twenty":-0.925604,"median":-0.860947,"eighty":-0.599346,"marketCap":31419614},{"date":"2023-10-20","current":-0.89838,"twenty":-0.951466,"median":-0.884768,"eighty":-0.62041,"marketCap":30495508},{"date":"2023-10-27","current":-0.78268,"twenty":-0.946021,"median":-0.884768,"eighty":-0.631899,"marketCap":26568056},{"date":"2023-11-03","current":-0.911992,"twenty":-0.929687,"median":-0.884768,"eighty":-0.712322,"marketCap":30957561},{"date":"2023-11-10","current":-1.000469,"twenty":-0.959633,"median":-0.891574,"eighty":-0.763066,"marketCap":33960907},{"date":"2023-11-17","current":-1.104073,"twenty":-0.980051,"median":-0.89838,"eighty":-0.780289,"marketCap":37297800},{"date":"2023-11-24","current":-1.270365,"twenty":-0.999262,"median":-0.911992,"eighty":-0.786996,"marketCap":42915471},{"date":"2023-12-01","current":-1.256631,"twenty":-1.107415,"median":-0.925604,"eighty":-0.801891,"marketCap":42451520},{"date":"2023-12-08","current":-1.373368,"twenty":-1.121435,"median":-0.939215,"eighty":-0.813987,"marketCap":46395104},{"date":"2023-12-15","current":-1.359634,"twenty":-1.252511,"median":-0.959633,"eighty":-0.824876,"marketCap":45931152},{"date":"2023-12-22","current":-1.339033,"twenty":-1.319806,"median":-0.973245,"eighty":-0.842572,"marketCap":45235226},{"date":"2023-12-29","current":-1.45577,"twenty":-1.339033,"median":-0.980051,"eighty":-0.854822,"marketCap":49178810},{"date":"2024-01-05","current":-1.929581,"twenty":-1.359634,"median":-0.986857,"eighty":-0.867073,"marketCap":65185121},{"date":"2024-01-12","current":-2.217989,"twenty":-1.373368,"median":-1.000469,"eighty":-0.876601,"marketCap":74928092},{"date":"2024-01-19","current":-2.423994,"twenty":-1.431049,"median":-1.101384,"eighty":-0.882046,"marketCap":81887358},{"date":"2024-01-26","current":-2.746735,"twenty":-1.572506,"median":-1.114716,"eighty":-0.884768,"marketCap":92790208},{"date":"2024-02-02","current":-2.526996,"twenty":-1.981769,"median":-1.12197,"eighty":-0.888852,"marketCap":85366991},{"date":"2024-02-09","current":-2.544163,"twenty":-2.252323,"median":-1.229164,"eighty":-0.891574,"marketCap":85946930},{"date":"2024-02-16","current":-2.629999,"twenty":-2.386913,"median":-1.263498,"eighty":-0.895658,"marketCap":88846624},{"date":"2024-02-23","current":-2.307258,"twenty":-2.444594,"median":-1.290965,"eighty":-0.89838,"marketCap":77943774},{"date":"2024-03-01","current":-2.499529,"twenty":-2.444594,"median":-1.339033,"eighty":-0.901102,"marketCap":84439089},{"date":"2024-03-08","current":-2.465195,"twenty":-2.469315,"median":-1.352767,"eighty":-0.907908,"marketCap":83279211},{"date":"2024-03-15","current":-2.101428,"twenty":-2.462448,"median":-1.366501,"eighty":-0.914714,"marketCap":79131372},{"date":"2024-03-22","current":-2.062751,"twenty":-2.444594,"median":-1.373368,"eighty":-0.92152,"marketCap":77674966},{"date":"2024-03-28","current":-2.030521,"twenty":-2.423994,"median":-1.407702,"eighty":-0.925604,"marketCap":76461295},{"date":"2024-04-05","current":-1.991844,"twenty":-2.422621,"median":-1.469503,"eighty":-0.926965,"marketCap":75004889},{"date":"2024-04-12","current":-1.959549,"twenty":-2.40614,"median":-1.575939,"eighty":-0.933771,"marketCap":73788790},{"date":"2024-04-19","current":-1.96606,"twenty":-2.361505,"median":-1.8178,"eighty":-0.940576,"marketCap":74033952},{"date":"2024-04-26","current":-1.868793,"twenty":-2.353952,"median":-1.846646,"eighty":-0.948743,"marketCap":70371251},{"date":"2024-05-03","current":-1.810595,"twenty":-2.330605,"median":-1.843584,"eighty":-0.959633,"marketCap":68179759},{"date":"2024-05-10","current":-1.810595,"twenty":-2.314124,"median":-1.846646,"eighty":-0.960994,"marketCap":68179759},{"date":"2024-05-17","current":-1.644574,"twenty":-2.312751,"median":-1.842927,"eighty":-0.9678,"marketCap":78406723},{"date":"2024-05-24","current":-1.659896,"twenty":-2.304511,"median":-1.810595,"eighty":-0.974606,"marketCap":79137220},{"date":"2024-05-31","current":-1.644574,"twenty":-2.293524,"median":-1.794429,"eighty":-0.980051,"marketCap":78406723},{"date":"2024-06-07","current":-1.736507,"twenty":-2.272923,"median":-1.736507,"eighty":-0.980051,"marketCap":82789707},{"date":"2024-06-14","current":-1.976554,"twenty":-2.261937,"median":-1.746722,"eighty":-0.985496,"marketCap":94234167},{"date":"2024-06-21","current":-2.009118,"twenty":-2.238589,"median":-1.746722,"eighty":-0.993817,"marketCap":95786700},{"date":"2024-06-28","current":-2.447891,"twenty":-2.25919,"median":-1.772259,"eighty":-0.998457,"marketCap":116705635},{"date":"2024-07-05","current":-2.528717,"twenty":-2.308631,"median":-1.797662,"eighty":-1.000067,"marketCap":120559123},{"date":"2024-07-12","current":-2.644184,"twenty":-2.359446,"median":-1.814198,"eighty":-1.000469,"marketCap":126064106},{"date":"2024-07-15","current":-2.540264,"twenty":-2.362192,"median":-1.8178,"eighty":-1.000469,"marketCap":121109621},{"date":"2024-08-02","current":-1.974478,"twenty":-2.361505,"median":-1.830364,"eighty":-1.020114,"marketCap":94135205},{"date":"2024-08-09","current":-1.29534,"twenty":-2.353952,"median":-1.810595,"eighty":-1.09977,"marketCap":84501485},{"date":"2024-08-16","current":-1.754315,"twenty":-2.330605,"median":-1.781728,"eighty":-1.105744,"marketCap":114442745},{"date":"2024-08-23","current":-2.093692,"twenty":-2.314124,"median":-1.810595,"eighty":-1.112886,"marketCap":136581967},{"date":"2024-08-30","current":-2.140682,"twenty":-2.312751,"median":-1.830364,"eighty":-1.115007,"marketCap":139647398},{"date":"2024-09-06","current":-2.109355,"twenty":-2.307258,"median":-1.845034,"eighty":-1.116169,"marketCap":137603777},{"date":"2024-09-13","current":-2.271212,"twenty":-2.293524,"median":-1.853208,"eighty":-1.119295,"marketCap":148162483},{"date":"2024-09-20","current":-1.99971,"twenty":-2.272923,"median":-1.868793,"eighty":-1.124646,"marketCap":130451106},{"date":"2024-09-27","current":-2.04148,"twenty":-2.271212,"median":-1.875815,"eighty":-1.198295,"marketCap":133175933},{"date":"2024-10-04","current":-1.989268,"twenty":-2.26599,"median":-1.888192,"eighty":-1.198295,"marketCap":129769899},{"date":"2024-10-11","current":-1.957941,"twenty":-2.25919,"median":-1.894658,"eighty":-1.201697,"marketCap":127726278},{"date":"2024-10-18","current":-1.871792,"twenty":-2.245106,"median":-1.91272,"eighty":-1.229164,"marketCap":122106322},{"date":"2024-10-25","current":-1.68644,"twenty":-2.224855,"median":-1.894658,"eighty":-1.249764,"marketCap":110014901},{"date":"2024-10-31","current":-1.655113,"twenty":-2.224348,"median":-1.888192,"eighty":-1.255258,"marketCap":107971280},{"date":"2024-11-08","current":-1.978826,"twenty":-2.219235,"median":-1.891425,"eighty":-1.263969,"marketCap":129088692},{"date":"2024-11-15","current":-1.99971,"twenty":-2.191779,"median":-1.91095,"eighty":-1.269453,"marketCap":130451106},{"date":"2024-11-22","current":-2.764944,"twenty":-2.238694,"median":-1.926614,"eighty":-1.270365,"marketCap":149865500},{"date":"2024-11-29","current":-2.639886,"twenty":-2.266998,"median":-1.927383,"eighty":-1.284312,"marketCap":143087085},{"date":"2024-12-06","current":-2.748287,"twenty":-2.299018,"median":-1.929581,"eighty":-1.294648,"marketCap":148962642},{"date":"2024-12-13","current":-2.525108,"twenty":-2.344339,"median":-1.940802,"eighty":-1.305076,"marketCap":136865908},{"date":"2024-12-20","current":-2.250917,"twenty":-2.413049,"median":-1.95272,"eighty":-1.323927,"marketCap":122004205},{"date":"2024-12-27","current":-2.646262,"twenty":-2.438332,"median":-1.956124,"eighty":-1.334913,"marketCap":143432706},{"date":"2025-01-03","current":-2.168022,"twenty":-2.456241,"median":-1.957941,"eighty":-1.339033,"marketCap":117511133},{"date":"2025-01-10","current":-2.168022,"twenty":-2.447891,"median":-1.959614,"eighty":-1.339033,"marketCap":117511133},{"date":"2025-01-17","current":-2.046868,"twenty":-2.423994,"median":-1.970269,"eighty":-1.3459,"marketCap":110944334},{"date":"2025-01-24","current":-2.091504,"twenty":-2.423994,"median":-1.97769,"eighty":-1.356887,"marketCap":113363681},{"date":"2025-01-31","current":-1.976726,"twenty":-2.4185,"median":-1.976554,"eighty":-1.359634,"marketCap":107142503},{"date":"2025-02-07","current":-1.937476,"twenty":-2.411689,"median":-1.970269,"eighty":-1.365128,"marketCap":105015096},{"date":"2025-02-14","current":-2.114955,"twenty":-2.389925,"median":-1.974478,"eighty":-1.371995,"marketCap":114634800},{"date":"2025-02-21","current":-2.366383,"twenty":-2.395026,"median":-1.976726,"eighty":-1.373368,"marketCap":128262713},{"date":"2025-02-28","current":-2.329409,"twenty":-2.395026,"median":-1.980336,"eighty":-1.373368,"marketCap":126258608},{"date":"2025-03-07","current":-1.885712,"twenty":-2.395026,"median":-1.984047,"eighty":-1.389848,"marketCap":102209349},{"date":"2025-03-14","current":-2.414629,"twenty":-2.395026,"median":-1.984047,"eighty":-1.409075,"marketCap":130266818},{"date":"2025-03-21","current":-2.446524,"twenty":-2.415305,"median":-1.989268,"eighty":-1.43929,"marketCap":131987517},{"date":"2025-03-28","current":-2.008566,"twenty":-2.412303,"median":-1.989268,"eighty":-1.46401,"marketCap":108360122},{"date":"2025-04-04","current":-2.197341,"twenty":-2.410499,"median":-1.989268,"eighty":-1.510704,"marketCap":118544344},{"date":"2025-04-11","current":-1.691424,"twenty":-2.404863,"median":-1.989268,"eighty":-1.550532,"marketCap":91250629},{"date":"2025-04-17","current":-1.58571,"twenty":-2.39466,"median":-1.984722,"eighty":-1.546412,"marketCap":85547464},{"date":"2025-04-25","current":-1.638567,"twenty":-2.383364,"median":-1.984047,"eighty":-1.56571,"marketCap":88399046},{"date":"2025-05-02","current":-1.668771,"twenty":-2.381173,"median":-1.980336,"eighty":-1.579955,"marketCap":90028522},{"date":"2025-05-05","current":-1.540404,"twenty":-2.381173,"median":-1.978826,"eighty":-1.56918,"marketCap":83103251}],"updateTime":1746593066867}}}